Key result
Hormonal therapy for infantile spasms is linked to a 44% hypertension rate versus nonhormonal treatments.
Why the study?
Hormonal therapies for infantile spasms cause systemic side effects including hypertension and fatal cardiomyopathy, but their incidence has not been well described.
Does hormonal therapy (ACTH or prednisolone) increase the incidence of hypertension in children with infantile spasms compared to nonhormonal therapies?
Observational
No
Does hormonal therapy (ACTH or prednisolone) increase the incidence of hypertension in children with infantile spasms compared to nonhormonal therapies?
Absolute Event Rate: 44% vs 0%
p-value: p=<.001
Hormonal therapy for infantile spasms frequently causes short-term hypertension, but rarely leads to long-term hypertension or cardiomyopathy.
May warrant BP monitoring during hormonal therapy for infantile spasms; leaves open long-term cardiovascular sequelae.
Children with infantile spasms are often treated with hormonal therapies including adrenocorticotropic hormone (ACTH) and prednisolone. These have numerous systemic side effects including hypertension and, rarely, fatal cardiomyopathy; however, the incidence of these side effects has not been well described. This study aims to quantify the incidence and short-term sequelae of hypertension in this population. A retrospective chart review was performed at a single institution. Children 2 months to 2 years old with newly diagnosed infantile spasms treated from 2013 to 2017 were included. Variables collected included age, sex, etiology and treatment of infantile spasms, documented or missed diagnosis of hypertension, treatment of hypertension, echocardiogram results, referrals for hypertension, and persistence of hypertension 2 to 4 months after treatment. Analyses included descriptive statistics with percentiles, means, and medians. Differences between groups were assessed using Fisher exact tests. Hypertension occurred in 34/77 children (44%) during treatment with ACTH and 4/11 children (36%) during treatment with prednisolone. No child developed hypertension during treatment with nonhormonal therapies. The incidence of hypertension between ACTH and prednisolone groups was not significantly different ( P = .75). The incidence of hypertension was significantly higher in the ACTH and prednisolone groups compared to the nonhormonal group ( P < .001 for each). Sixteen children received echocardiograms, with no cases of cardiomyopathy. Two children had persistent hypertension at 2 months after discontinuation of hormonal therapy. Hypertension is a very common side effect of hormonal therapy for infantile spasms; however, few developed long-term hypertension and none developed cardiomyopathy. Further study is needed to determine the role of antihypertensive treatment for hormone-related hypertension.
No takes yet. Share an insight, caveat, or question.
McGarry et al. (2019) conducted an observational in Infantile spasms. Adrenocorticotropic hormone (ACTH) or prednisolone vs. Nonhormonal therapies was evaluated on Incidence of hypertension (p=<.001). Hormonal therapy with ACTH or prednisolone for infantile spasms resulted in hypertension in 44% and 36% of children, respectively, compared to 0% with nonhormonal therapies (P < .001 for each).
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: